Open Philanthropy recommended a contract of $421,969 over four years with Viroclinics Biosciences to support in vivo testing of broad-spectrum antivirals.
This falls within Open Philanthropy’s focus area of scientific research, specifically within its interest in science supporting biosecurity and pandemic preparedness.